Larvol Delta - Phase-1-trial-of-prulacel-demonstrating-strong-enrollment-momentum-across-multiple-autoimmune-indications-with-next-clinical-update-expected-in-the-first-half-of-2026

prulacabtagene leucel (ADI-001) - Adicet Bio

https://www.pharmiweb.com/press-release/2026-03-12/adicet-bio-reports-fourth-quarter-and-full-year-2025-financial-results-and-highlights-recent-company

Mar 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next